Here again, if we query cancer datasets, CHEK1/CDK being cell-cycle regulators, are seen overexpressed in most aggressive tumours (e.g. triple-negative breast cancers), and but are not necessarily mutually exclusive to MYC overexpression. This evidence concerns the gene CHEK1 and neoplasm.